ArchIntel

JUNE 2, 2021

pharmaceutical industry in 2021 and beyond. The race to create new products against COVID-19 amid the emergence of new mutations is expected to eclipse every other effort in health care and pharmaceuticals this year. This fierce competition is predicted to propel the U.S. ArchIntel™ -. These are some of the U.S.

Pharmaceutical 104

Pharmaceutical Competitive Competitive Intelligence Profiling 104

ArchIntel

JANUARY 13, 2021

In light of the opportunities and challenges faced by the A&D industry this year, knowing how competitors intend to adapt is strategically important, making the role of competitive intelligence executives critical. Stefanie Kowitt is the head of Lockheed Martin’s capture excellence and competitive intelligence team.

Competitive Intelligence 104

Competitive Intelligence Pharmaceutical Profiling Briefing 104

ArchIntel

APRIL 21, 2021

While the United States manufacturing sector took a hit from COVID-19-spawned disruptions, it is important to note that the industry churns out the goods needed to sustain the needs and wants of the world’s largest consumer market. Anupama Pokharna Senior Market, CI Manager Western Digital. As of 2019, there were some 12.8

Competitive Intelligence 104

Competitive Intelligence Profiling Competitive Pharmaceutical 104

ArchIntel

MARCH 17, 2021

health care sector is seen to experience an unprecedented level of competition. Through all this, competitive intelligence professionals will surely be pushed hard to generate much-needed insights. Executive Profile: Arnold DuBell, Associate Competitive and Strategic Intelligence Director at Novartis.

Pharmaceutical 104

Pharmaceutical Competitive Competitive Intelligence Profiling 104